Download PDF
Hamostaseologie 1986; 06(01): 44-56
DOI: 10.1055/s-0038-1655137
Originalarbeiten
Schattauer GmbH

Genetisch bedingte Fehlfunktionen der Gerinnungsfaktoren

E Deutsch
1   I. Medizinischen Universitätsklinik, Wien
› Author Affiliations
Further Information

Publication History

Publication Date:
25 June 2018 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Es wird eine Übersicht über eine Auswahl der derzeit bekannten Varianten der wichtigsten Gerinnungsfaktoren gegeben. Gleichzeitig wird auf die chromosomale Lokalisation der Gene, die möglichen Größen der Gene und der derzeit verfügbaren cDNA’s hingewiesen, wobei diese Angaben nur einen präliminären grob informativen Charakter haben.

* Herrn Prof. Dr. Dr. h. c. H. G. Lasch zum 60. Geburtstag


 

  • Literatur

  • 1 Aiach M, Nora M, Fiessinger J N, Roncato M, Francois D, Gelas M A. A functional abnormal antithrombin III (AT III) deficiency: AT VIII Charleville. Thromb Res 1985; 39: 559-70.
    CrossrefPubMedSearch in Google Scholar
  • 2 Anson D S, Choo K H, Rees D J G, Gianelli K G, Huddlestone J A, Brownlee G S. The gene-structure of human antihaemophilic factor IX. EMBO J 1984; 03 5, 1053-60.
    PubMedSearch in Google Scholar
  • 3 Antonarakis E S, Copeland K, Carpenter Jr. R J, Carta C A, Hoyer L W, Caskey C T, Toole J J, Kazazian Jr. H H. Prenatal diagnosis of haemophilia A by factor VIII gene analysis. Lancet 1985; I: 1407-9.
    PubMedSearch in Google Scholar
  • 4 Bahnak B R, Howk R, Millstein L, Edgington T S, Jaye M C, Drohan W W, Fair D S. Characterization of a human factor X cDNA clone and analysis of factor X transcription by human hepatoma cells. Thromb Haemost 1985; 54: 168.
    PubMedSearch in Google Scholar
  • 5 Barbui T, Finazzi G. Characterization of a new variant of inherited dysfunctional antithrombin (AT “Vicenca”). Thromb Haemost 1983; 50: 360.
    PubMedSearch in Google Scholar
  • 6 Bauer K A, Ashenhurst J B, Chediak J, Rosenberg R D. Antithrombin “Chicago”: a functionally abnormal molecule with increased heparin affinity causing familial thrombophilia. Blood 1983; 62: 1242-50.
    PubMedSearch in Google Scholar
  • 7 Beck E A. Hereditäre Dysfibrinogenämie. Hämostaseologie 1983; 03: 102-6.
    Thieme ConnectPubMedSearch in Google Scholar
  • 8 Beck E A, Furlan M. Variants of Human Fibrinogen. H. Huber; Bern Stuttgart Toronto: 1984
    Search in Google Scholar
  • 9 Benarous R, Rabiet M J, Labie D, Josso F. Activation studies on a human prothrombin variant: prothrombin Barcelona. Thromb Haemost 1977; 38: 188.
    PubMedSearch in Google Scholar
  • 10 Bertina R M. Genetic variants of factor IX. In: Haemophilia. Seligsohn U, Rimon A, Horoszowski H. (Eds). Castle House; Tunbridge Wells: 1981: 19-27.
    Search in Google Scholar
  • 11 Bertina R M, Alderkamp G J H, de Nooy E. A variant of factor X that is defective only in extrinsic coagulation. Thromb Haemost 1981; 46: 88.
    PubMedSearch in Google Scholar
  • 12 Bertina R M, van der Linden I K. A genetic variant of factor IX with an abnormal high molecular weight. Thromb Haemost 1981; 46: 125.
    Thieme ConnectPubMedSearch in Google Scholar
  • 13 Bertina R. M, van der Linden I K: Factor IX Deventer evidence for the heterogeneity of hemophilia BM . Thromb Haemost 1982a 47: 136-40.
    PubMed
  • 14 Bertina R M, van der Linden I. Factor IX Zutphen. A genetic variant of blood coagulation of factor IX with an abnormally high molecular weight. J Lab Clin Med 1982b 100: 695-704.
    PubMed
  • 15 Bertina R M. Variants of hemophilia B. VIII Int Kongr Thromb Istanbul 1984; 82.
    PubMedSearch in Google Scholar
  • 16 Berrettini M, Lämmle B, Ciavarella G, Ciavarella N. Functional and immunological studies of abnormal factor XII in a cross reacting material positive (CRM+) factor XII deficiency. Thromb Haemost 1985; 54: 120.
    PubMedSearch in Google Scholar
  • 17 Bezeaud A, Guillin M-C, Olmeda F, Quintana M, Gomee N. Prothrombin Madrid: A new familial abnormality of prothrombin. Thromb Res 1979; 16: 47-58.
    CrossrefPubMedSearch in Google Scholar
  • 18 Bloom A L. Inherited disorders of blood coagulation. In: Haemostasis and Thrombosis. Bloom A L, Thomas D P. (Eds). Churchill Livingstone; Edinbourgh London Melbourne New York: 1981: 321-70.
    Search in Google Scholar
  • 19 Boyer C, Tripodi A, Wolf M, Mannucci P M, Larrieu M J. A new familial variant of antithrombin III: “Antithrombin III Milano”. Thromb Haemost 1983; 50: 51.
    PubMedSearch in Google Scholar
  • 20 Boyer C, Wolf M, Vedrenne J, Larrieu M J. Antithrombine III Fontainebleau: un variant homozygote de l’antithrombine III. Nouv Rev Fr Hematol 1985; 27: 106.
    PubMedSearch in Google Scholar
  • 21 Borg J Y, Soria J, Soria C, Legendre M, Piguet H, Moncoduit M. Antithrombin III variants Rouen with defective heparincofactor activities and low thrombotic incidence. Thromb Haemost 1985; 54: 88.
    PubMedSearch in Google Scholar
  • 22 Bock S C, Levitan D J. Characterization of an unusual DNA length polymorphism 5’ to the human antithrombin III gene. Nucl Acid Res 1983; 11: 8569-82.
    CrossrefPubMedSearch in Google Scholar
  • 23 Bock S C, Harris J F, Balasz I, Trent J M. Assignment of the human antithrombin III structural gene to chromosome lq23-25. Cytogenet Cell Genet 1985a 39: 67-9.
    PubMed
  • 24 Bock S C, Harris J F, Schwartz C E, Ward J H, Hershgold E J, Skolnick M H. Hereditary thrombosis in a Utah kindred is caused by a dysfunctional antithrombin III-gene. Amer J Hum Genet 1985; b; 37: 32-41.
    PubMedSearch in Google Scholar
  • 25 Briet E, Bertina R M, van Tilberg N H, Veltkamp J J. Hemophilia B Leyden. A sex-linked hereditary disorder that improves after puberty. New Engl J Med 1982; 306: 788-90.
    CrossrefPubMedSearch in Google Scholar
  • 26 Camerino G, Grzeschnik K H, Jaye M, De La HSalle, Tolshoshev P, Lecocq J D. Reginal localization on the human X Chromosom and polymorphism of the coagulation factor IX gene (hemophia B locus). Proc Natl Acad Sci (USA) 1984; 81: 498-502.
    CrossrefPubMedSearch in Google Scholar
  • 27 Chung D W, Chan W-Y, Davie E W. Characterization of a complementary deoxynucleic acid coding for the y-chain of human fibrinogen. Biochemistry 1983a 22: 3250-6.
    PubMed
  • 28 Chung D W, Que B G, Rixon M W, Mace Jr. M, Davie E W. Characterization of complementary deoxyribonucleic acid and genomic deoxyribonucleic acid for the ß chain of human fibrinogen. Biochemistry 1983b 22: 3244-50.
    PubMed
  • 29 Chung D W, Rixon M W, Que B G, Davie E W. Cloning of fibrinogen genes and their cDNA. Ann NY Acad Sci 1983c 408: 449-56.
    PubMed
  • 30 Cool D E, Edgell C-JS, MacGillivray R T A. Characterization of human factor XII cDNA. Thromb Haemost 1985; 54: 120.
    PubMedSearch in Google Scholar
  • 31 Cosgriff T M, Bishop D T, Hershgold E J, Skolnick M H, Martin B A, Baty B J, Carlson K S. Familial antithrombin III deficiency: its natural history, genetics, diagnosis and treatment. Medicine 1983; 62: 209-20.
    CrossrefPubMedSearch in Google Scholar
  • 32 Crabtree G R, Plutzky J, Marier R, Bertina R M, Brockmans A W, Griffin J, Zacharski L, Gruppo R, Sala N, Long G. The range of genotypes underlying human protein C deficiency. Thromb Haemost 1985; 54: 56.
    PubMedSearch in Google Scholar
  • 33 Denson K W E, Lurie A, DeCataldo F, Mannucci P M. The factor X defect: Recognization of abnormal forms of factor X. Brit J Haematol 1970; 18: 317-27.
    CrossrefPubMedSearch in Google Scholar
  • 34 Deutsch E. Pathophysiologie der plasmatisch bedingten Coagulopathien. In: Hämorrhagische Diathesen, Int. Symp. Wien 1955. Jürgens R, Deutsch E. (Eds). Springer, Wien; 1955: 71-8.
    Search in Google Scholar
  • 35 Deutsch E. Verschiedene Formen der Hämophilie. Thromb Diath Hämorrh 1957; 01: 93-113.
    PubMedSearch in Google Scholar
  • 36 Din N, Schwartz M, Kruse T, Vestergaard S R, Ahrens P, Caput D, Hartog K, Quiroga M. Factor VIII gene specific probe for prenatal diagnosis of haemophilia A. Lancet 1985; I: 1446-7.
    PubMedSearch in Google Scholar
  • 37 Doolittle R F. Fibrinogen and Fibrin. Ann Rev Biochem 1984; 53: 195-229.
    CrossrefPubMedSearch in Google Scholar
  • 38 Fair D, Revak D, Edgington T, Girolami A. Structural studies on the factor X Friuli variant. Thromb Haemost 1983; 50: 272.
    PubMedSearch in Google Scholar
  • 39 Fair D S, Edgington T S. Heterogeneity of hereditary and acquired factor X deficiencies by combined immunochemical and functional analysis. Brit J Haemat 1985; 59: 235-48.
    CrossrefPubMedSearch in Google Scholar
  • 40 Fantl P, Sawers R J. Haemophilia: A syndrome under review. Investigations of alpha and beta prothromboplastin deficiencies. Australian Ann Med 1954; 03: 245-62 Abstract: Blood 1956; 11: 681.
    PubMedSearch in Google Scholar
  • 41 Felez J, Grau F, Fontcuberta J, Soto R, Diego I, Rueda F, Rutilant M L. Qualitative and quantitative congenital deficiency of antithrombin-III: a new molecular variant provisionally called AT-III-Barcelona. Thromb Haemost 1985; 54: 90.
    PubMedSearch in Google Scholar
  • 42 Filippi G, Mannucci P M, Coppola R, Farris A, Rinaldi A, Siniscalco M. Studies on hemophilia A in Sardinia bearing on the problems of multiple allelism, carrier detection, and differential mutation rate in two sexes. Amer J Hum Gen 1984; 36: 44-71.
    PubMedSearch in Google Scholar
  • 43 Finazzi G, Tran T H, Barbui T, Duckert F. Purification of antithrombin “Vicenca”: a molecule with normal heparin affinity and impaired reactivity to thrombin. Brit J Haemat 1985; 59: 259-63.
    CrossrefPubMedSearch in Google Scholar
  • 44 Fischer A-M, Gazengel C, Dautzenberg M-D, Benhammo J, Béguin S, Vergoz D. A new case of abnormal antithrombin III (AT III): biological characteristics and thromboembolic accidents management. Thromb Haemost 1983; 50: 358.
    PubMedSearch in Google Scholar
  • 45 Foster D C, Yoshitake S, Davie E W. Characterization of the gene for human protein C. Thromb Haemost 1985; 54: 55.
    PubMedSearch in Google Scholar
  • 46 Friezner S JDegen, MacGillivray R T A, Davie E W. Characterization of complimentary deoxyribonucleic acid and gen coding human prothrombin. Biochemistry 1983; 22: 2087-97.
    CrossrefPubMedSearch in Google Scholar
  • 47 Fung M R, Campbell R M, MacGillivray R T A. Blood coagulation factor X mRNA encodes a single polypeptide chain containing a pre-pro-leader sequence. Nucl Acid Res 1984; 12: 4481-92.
    CrossrefPubMedSearch in Google Scholar
  • 48 Fung M R, Hay C W, MacGillivray R T A. Characterization of the gene coding for human factor X. Thromb Haemost 1985; 54: 168.
    PubMedSearch in Google Scholar
  • 49 Gianelli F, Anson D, Brownlee G G, Choo K H, Rees D J G, Boyd Y, Edwards J H, Rizza C. Molecular defects in the gene for human coagulation factor IX. Thromb Haemost 1983; 50: 324.
    PubMedSearch in Google Scholar
  • 50 Ginsburg D, Handin R I, Bonthron D T, Donlon T A, Bruns G A P, Latt S A, Orkin S H. Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization. Science 1985; 228: 1401-6.
    CrossrefPubMedSearch in Google Scholar
  • 51 Girolami A, Molaro G, Lazzarin M, Scarpa R, Brunetti A. A “new” congenital haemorrhagic condition due to the presence of an abnormal factor X (factor X Friuli): a study of a large kindred. Brit J Haemat 1970; 19: 179-92.
    CrossrefPubMedSearch in Google Scholar
  • 52 Girolami A, Lazzarin M, Molaro G. The effect of several tissue thromboplastins on the activation of the abnormal factor X (factor X Friuli). Thromb Diath Haemorrh 1972a 27: 535-42.
    PubMed
  • 53 Girolami A, Sticchi A, Bareggi G. Crossover electrophoresis (electrosyneresis) visualization of the abnormal factor X (factor X Friuli). J Lab Clin Med 1972b 80: 740-7.
    PubMed
  • 54 Girolami A. Prothrombin Padua. In: Prothrombin and Related Coagulation Factors. Hemker H C, Veitkamp J J. (Eds). Leiden: University Press; 1975: 213-22.
    Search in Google Scholar
  • 55 Girolami A, Falezza G, Patrassi G M, Stenico M, Vettore L. Factor VII Verona: Double heterozygous between an abnormal factor VII and factor VII heterozygous deficiency. Blood 1977; 50: 603-10.
    PubMedSearch in Google Scholar
  • 56 Girolami A, Fabris F, Dal bo Zanon R, Ghiotto G. Factor VII Padua: A congenital coagulation disorder due to an abnormal factor VII with a peculiar activation pattern. J Lab Clin Med 1978; 91: 387.
    PubMedSearch in Google Scholar
  • 57 Girolami A, Cattarozzi G, Dal bo Zanon R, Celia G, Toffanin F. Factor VII Padua 2: an other factor VII abnormality with defective ox brain thromboplastin and a complex hereditary pattern. Blood 1979a 54: 46-53.
    PubMed
  • 58 Girolami A, Saggin L, Boeri G. Factor X assays using chromogenic substrates S-222. Amer J Clin Path 1979b 73: 400-2.
    PubMed
  • 59 Girolami A. The congenital variants of the prothrombin complex factors. Acta Haemat 1980; 63: 339-41.
    CrossrefPubMedSearch in Google Scholar
  • 60 Girolami A, Fabris F, Cappellato G, Sainati L, Boeri G. Antithrombin III (AT III) Padua2: A “new” congenital abnormality with defective heparin co-factor activities but no thrombotic disease. Blut 1983; 47: 93-103.
    CrossrefPubMedSearch in Google Scholar
  • 61 Girolami A, Marafioti F, Rubertelli M, Vicarioto M A, Cappellato G, Mazzuccato M. Antithrombin III Trento a new congenital AT III abnormality with a peculiar crossed-immunoelectrophoretic pattern in the absence of heparin. Acta Haemat 1984a 72: 73-82.
    PubMed
  • 62 Girolami A, Patrassi G, Fabris F, Vicarioto M A. Faktor-VII-Mangel und Varianten. Hämostaseologie 1984b 04: 98-104.
    PubMed
  • 63 Girolami A, Vicarioto M, Ruzza G, Cappellato G, Vergolani A. Factor X Padua: a “new” congenital factor X abnormality with a defect only in the extrinsic system. Acta Haemat 1985; 73: 31-6.
    CrossrefPubMedSearch in Google Scholar
  • 64 Goodnight S H, Feinstein D I, Osterud B, Rapaport S I. F Vll-antibody-neutralizing material in hereditary and acquired F VIIdeficiency. Blood 1971; 38: 1-8.
    PubMedSearch in Google Scholar
  • 65 Goossens M, Daffos F, Forestier F, Gazengel C. First trimester prenatal diagnosis of severe Christmas disease. Thromb Haemat 1985; 54: 274.
    PubMedSearch in Google Scholar
  • 66 Guinto E R, MacGillivray R T A. In vitro transcription of prothrombin cDNA using SP6 RNA. Thromb Haemost 1985; 54: 46.
    PubMedSearch in Google Scholar
  • 67 Hassan H J, Leonardi A, Guerriero R, Chelucci C, Cianetti L, Ciavarella N, Ranieri P, Pilolli D, Peschle C. Hemophilia B inhibitor: molecular analysis for the subtotal deletion of the factor IX gene. Blood 1985; 66: 728-30.
    PubMedSearch in Google Scholar
  • 68 Hellstern P, Mannhalter C, Köhler M, Kiehl R, van Blohn G, Wenzel E, Deutsch E. Combined dys-form of homozygous factor Xl-deficiency and heterozygous factor XH-deficiency. Haemostasis 1985; 15: 215-9.
    PubMedSearch in Google Scholar
  • 69 Henrikson R A, Owen W G. Action of thrombin Quick I on protein substrates. Thromb Haemost 1985; 54: 262.
    PubMedSearch in Google Scholar
  • 70 Henschen A. Fibrinogen Blutgerinnungsfaktor I; Biochemische Aspekte. Hämostaseologie 1981; 01: 30-40.
    Thieme ConnectPubMedSearch in Google Scholar
  • 71 Henschen A. Fehlbildungen des Fibrinogens. Symposium Blutgerinnung: Physiologie, Pathophysiologie und Klinik. (Bad Nauheim IX/1985
    PubMed
  • 72 Hougie C, Barrow E M, Graham J B. Stuart clotting defect I. Segregation of an hereditary state from the heterogenous group heretofore called “stable factor”, (SPCA, Procouvertin, Factor VII) deficiency. J Clin Invest 1957; 36: 485-96.
    CrossrefPubMedSearch in Google Scholar
  • 73 Howarth D J, Samson D, Stirling Y, Seghatchian M J. Antithrombin III “Northwick Park”: a variant antithrombin with normal affinity for heparin but reduced heparin cofactor activity. Thromb Haemost 1985; 53: 314-9.
    Thieme ConnectPubMedSearch in Google Scholar
  • 74 Hoyer L W, Breckenridge R T. Immunologic studies of antihemophilic factor (AHF, Factor VIII): Cross-reacting material in a genetic variant of hemophilia A. Blood 1968; 32: 962-71.
    PubMedSearch in Google Scholar
  • 75 Huisse M G, Dreyfus M, Guillin M C. Prothrombin Clamart: prothrombin variant with defective ARG 322-ILE cleavage by factor Xa. Thromb Haemost 1985; 54: 46.
    PubMedSearch in Google Scholar
  • 76 Irwin D M, Ahern K, Pearson G, MacGillivray R T A. The structure of the bovine prothrombin gene. Thromb Haemost 1985; 54: 46.
    PubMedSearch in Google Scholar
  • 77 Kahn M J P. Prothrombin Brussels. In: Prothrombin and Related Coagulation Factors. Hemker H C, Veltkamp J J. (Eds). Leiden: University Press; 1975: 223-9.
    Search in Google Scholar
  • 78 Kant J A, Fornace Jr. A J, Saxe D, Simon M I, McBride O W, Crabtree G R. Evolution and organization of the fibrinogen locus on chromosome: gene duplication accompanied by transposition and inversion. Proc Natl Acad Sci 1985; 82: 2344-8.
    CrossrefPubMedSearch in Google Scholar
  • 79 Koide T, Takahashi K, Sakuragawa N. Antithrombin III Toyama: abnormal antithrombin III resulting from replacement of arginine-47 by cysteine at the heparinbinding site. Thromb Haemost 1983; 50: 162.
    Thieme ConnectPubMedSearch in Google Scholar
  • 80 Koide T, Odani S, Takahashi K, Ono T, Sakuragawa N. Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability. Proc Natl Acad Sci 1984; 81: 289-93.
    CrossrefPubMedSearch in Google Scholar
  • 81 Kurachi K, Davie E W. Isolation and characterization of cDNA coding for human factor IX. Proc Natl Acad Sci 1982; 79: 6461-4.
    CrossrefPubMedSearch in Google Scholar
  • 82 Lawn R M, Gitschier J, Wood W I, Wion K, Tuddenham E. Cloned factor VIII and studies of the molecular genetics of hemophilia A. Thromb Haemost 1985; 54: 54.
    PubMedSearch in Google Scholar
  • 83 Lechner K, Mähr G, Margaritella P, Deutsch E. Factor X Vorarlberg, a new variant of hereditary factor X deficiency. Thromb Haemost 1979; 42: 58.
    PubMedSearch in Google Scholar
  • 84 Leone G, De Stefano V, De Martini D, Bizzi B. Anithrombin III Roma: further evidence that defective binding to heparin is related to a pH 4,65-4,8 isoantithrombin. Thromb Haemost 1985; 54: 25.
    PubMedSearch in Google Scholar
  • 85 Lillicrap D P, Liddell M B, Matthews R J, Peake I R, Bloom A L. Comparison of phenotypic assessment and the use of restriction fragment length polymorphisms (RFLPs) in diagnosis of the carrier state in haemophilia B. Thromb Haemost 1985; 54: 273.
    Thieme ConnectPubMedSearch in Google Scholar
  • 86 Long G L, Bang N U, Beckman R J, Hoskins J A, Jaskunas S R, Little S P, Santerre R F, Crabtree G R. Cloning, DNA sequencing, and expression of genetic material cloning for human protein C. Thromb Haemost 1985; 54: 56.
    PubMedSearch in Google Scholar
  • 87 Mariani G, Mazzucconi M G. Factor VII congenital deficiency clinical picture and classification of the variants. Haemostasis 1983; 13: 169-77.
    PubMedSearch in Google Scholar
  • 88 Mattei M G, Baeteman M A, Heilig R, Oberle I, Davies K, Mandel J L, Mattei J E. Localization by in situ hybridization of the coagulation factor IX gene and of two polymorphic DNA probes with respect to the fragile X site. Hum Genet 1985; 69: 327-31.
    CrossrefPubMedSearch in Google Scholar
  • 89 Matthews R J, Liddell M B, Lillicrap O P, Peake I R. Gene analysis in haemophilia A. Thromb Haemost 1985; 54: 154.
    PubMedSearch in Google Scholar
  • 90 Mazzucconi M G, Bertina R M, Romoli D, Orlando M, Avvisati G, Mariani G. Factor VII activity and antigen in haemophilia B variants. Thromb Haemost 1980; 43: 16-9.
    PubMedSearch in Google Scholar
  • 91 McGraw R A, Davis L M, Noyes C M, Lundblad R L, Roberts H R, Graham J B, Stafford D W. Evidence for a prevalent dimorphism in the activation peptide of human coagulation factor IX. Proc Natl Acad Sci 1985; 82: 2847-51.
    CrossrefPubMedSearch in Google Scholar
  • 92 Mertens K, Cupers R, van der Linden I K, Bertina R M. The functional defect of factor IX Eindhoven a genetic variant of factor IX. Thromb Haemost 1983; 50: 249.
    Thieme ConnectPubMedSearch in Google Scholar
  • 93 Montgomery R R, Corrigan J J, Clarke S, Johnson J. Prothrombin Denver. A new dysprothrombinemia. Circulation 1980; Suppl III: 279.
    PubMedSearch in Google Scholar
  • 94 Mortensen J Z. Inherited AT-III deficiency fast and slow inactivation of thrombin and factor Xa. Thromb Res 1984; 33: 511-5.
    CrossrefPubMedSearch in Google Scholar
  • 95 Mosesson M W. Fibrinogen Heterogeneity. In: Molecular Biology of Fibrinogen and Fibrin. Mosesson M W, Doolittle R F. 1983. 408 97-113.
    Search in Google Scholar
  • 96 Murayama H, Matsuda M. Abnormal antithrombin III with defective biological and immunological functions found in a thrombophilic patient “antithrombin III Tokyo”. Thromb Haemost 1983; 50: 358.
    PubMedSearch in Google Scholar
  • 97 Noyes C M, Griffith M J, Roberts H R, Lundblad R L. Identification of the molecular defect in factor IXChapel Hill: substitution of histidine for arginine at position 145 (blood coagulation protein primary structure/amino acid substitution). Proc Natl Acad Sci 1983; 80: 4200-2.
    CrossrefPubMedSearch in Google Scholar
  • 98 Oberle I, Camerino G, Heilig R, Grunebaum L, Cazenave J-P, Crapanzano C, Mannucci P M, Mandel J-L. Genetic screening for hemophilia A (classic hemophilia) with a polymorphic DNA probe. New Engl J Med 1985; 312: 682-6.
    CrossrefPubMedSearch in Google Scholar
  • 99 Østerud B, Kasper C K, Lavine K K, Prodanos C, Rapaport S I. Purification and properties of an abnormal blood coagulation factor IX (Factor IXBm)/kinetics of its inhibition of factor X activation by factor VII and bovine tissue factor. Thromb Haemost 1981; 45: 55-9.
    Thieme ConnectPubMedSearch in Google Scholar
  • 100 Ott R, Pfeiffer R A. Evidence that activities of coagulation factor VII and X are linked to chromosome 13 (q34). Hum Hered 1984; 34: 123-6.
    CrossrefPubMedSearch in Google Scholar
  • 101 Owen M C, Brennan S O, Lewis J H, Carrell R W. Mutation of antitrypsin to antithrombin: antitrypsin Pittsburg (358 Met → Arg), a fatal bleeding disorder. N Engl J Med 1983; 309: 694-8.
    CrossrefPubMedSearch in Google Scholar
  • 102 Parekh V R, Mannucci P M, Ruggieri Z M. Immunological heterogeneity of hemophilia B. A multicentre study of 98 kindreds. Br J Haemat 1978; 40: 643-55.
    CrossrefPubMedSearch in Google Scholar
  • 103 Parkin J D, Madaras F, Sweet B, Castaldi P A. A further inherited variant of coagulation factor X. Australian N Z J Med 1974; 04: 561-4.
    PubMedSearch in Google Scholar
  • 104 Peake I R, Furlong B L, Bloom A L. Carrier detection by direct gene analysis in a family with haemophilia B (factor IX deficiency). Lancet 1984; I: 242-4.
    PubMedSearch in Google Scholar
  • 105 Penner J A, Hassouna M J, Hunter M J, Chockley M. A clinically silent antithrombin III defect in an Ann Arbor Family. Thromb Haemost 1979; 42: 186.
    Thieme ConnectPubMedSearch in Google Scholar
  • 106 Pfeiffer R A, Ott R, Gilgenkrantz S, Alexandre P. Deficiency of coagulation factors VII and X associated with deletion of a chromosome 13 (q34). Evidence from two cases with 46, XY, t (13; Y) (qll; q34). Hum Genet 1982; 62: 358-60.
    CrossrefPubMedSearch in Google Scholar
  • 107 Pfeiffer R A, Ott R, Taben K D. Clotting factors VII and X as useful markers of terminal deletion of chromosome 13. Hum Genet 1985; 69: 192.
    CrossrefPubMedSearch in Google Scholar
  • 108 Prochownik E V, Markham A F, Orkin S H. Isolation of a cDNA clone for human antithrombin III. J Biol Chem 1983; 258: 8389-94.
    PubMedSearch in Google Scholar
  • 109 Rabiet M J, Elion J, Labié D, Josso F. Purification and partial characterization of a new variant of human prothrombin. Prothrombin Metz. FEBS Lett 1979; 108: 287.
    CrossrefPubMedSearch in Google Scholar
  • 110 Rabiet M J. Prothrombin Molise: a mutant prothrombin characterized by a defect in the thrombin domain. Thromb Haemost 1985; 54: 46.
    PubMedSearch in Google Scholar
  • 111 Ragni M V, Sinha D, Sehman F, Lewis H J, Spero J A, Walsh P N. Comparison of bleeding tendency, factor XI coagulant activity and factor XI antigen in 25 factor XI deficient kindreds. Blood 1985; 65: 719-24.
    PubMedSearch in Google Scholar
  • 112 Reeve E B, Jacobson L, Bies R. Abnormal turnover of antithrombin III Denver (ATD). Thromb Haemost 1985; 54: 88.
    PubMedSearch in Google Scholar
  • 113 Rixon M W, Chan W Y, Davie E W, Chung D W. Characterization of a complementary deoxyribonucleic acid coding for the chain of human fibrinogen. Biochemistry 1983; 22: 3237-44.
    CrossrefPubMedSearch in Google Scholar
  • 114 Roberts H R, Griffith M J, Braunstein K M, Lundblad R L. Structural abnormalities of the vitamin K-dependent clotting factors. In: Hemophilia and Hemostasis. Menache D, Mac N, Surgenor D, Anderson H. (Eds). Alan R Liss; New York: 1981: 85-102.
    Search in Google Scholar
  • 115 Roberts D, Hayne O, Fraser E. A family with factor XII deficiency: a family study suggesting that factor XII levels are determinated by the presence of 3 codominant alleles with variable penetrance. Thromb Haemost 1981; 46: 257.
    Thieme ConnectPubMedSearch in Google Scholar
  • 116 Sakuragawa N, Takahashi T, Horikoshi I. Congenital abnormal antithrombin III. Thromb Haemost 1981; 46: 285.
    Thieme ConnectPubMedSearch in Google Scholar
  • 117 Sala N, Borrell M, Fontcuberta J, Felez J, Rutlland M L. Qualitative defect of protein C in a patient with recurrent venous thrombosis. Thromb Haemost 1985; 54: 142.
    PubMedSearch in Google Scholar
  • 118 Sas G. Hereditary antithrombin III deficiency: biochemical aspects. Haematologia 1984; 17: 81-6.
    PubMedSearch in Google Scholar
  • 119 Shapiro S S, Martinez J, Holburn R R. Congenital dysprothrombinemia. An inherital structural disorder of human prothrombin. J Clin Invest 1969; 48: 2251.
    CrossrefPubMedSearch in Google Scholar
  • 120 Shapiro S S, Maldonado N I, Fradera J, McCord S. Prothrombin San Juan: a complex new dysprothrombinemia. J Clin Invest 1974; 53: 73A.
    PubMedSearch in Google Scholar
  • 121 Shapiro S S. Prothrombin San Juan: a complex new dysprothrombinemia. In: Prothrombin and Related Coagulation Factors. Hemker H C, Veltkamp J J. (Eds). Leiden: Univ Press; 1975: 205-12.
    Search in Google Scholar
  • 122 SØrensen P J, Sas G, Peto I, Blasko G, Kremmer T, Samu A. Distinction of two pathologic antithrombin III molecules: Antithrombin “Aalborg” and Antithrombin III “Budapest”. Thromb Res 1982; 26: 211-9.
    CrossrefPubMedSearch in Google Scholar
  • 123 Stephens A W, Thalley B S, Hirs C H W. Antithrombin III Denver, a ser to leu394 variant without protease inhibitory activity. Thromb Haemost 1985; 54: 49.
    PubMedSearch in Google Scholar
  • 124 Stoll C, Roth M P. Partial 4q duplication due to inherited der (13), t(4:13) (g26âl34) mat in a girl with a deficiency of factor X. Human Gen 1980; 53: 303-4.
    PubMedSearch in Google Scholar
  • 125 Tonnesen T, Sondergaard F, Mikkelsen M, Davies K E, Old J, Winter R M, Hauge M. X-chromosome-specific probe DX13 for carrier detection and first trimester prenatal diagnosis in haemophilia A. Lancet 1984; 11: 1269-70.
    PubMedSearch in Google Scholar
  • 126 Toole J J, Knopf J L, Wozney J M, Sultzman L A, Buecker J L, Pittman D D, Kaufman R J, Brown E, Shoemaker C, Orr E C, Amphlett G N, Foster W B, Coe M L, Knutson G J, Fass D N, Hewick R M. Molecular cloning of a cDNA encoding human antihaemophilic factor. Nature 1984; 312: 342-6.
    CrossrefPubMedSearch in Google Scholar
  • 127 Tran T H, Bondeli C, Marbet G A, Duckert F. Reactivity of a hereditary abnormal antithrombin III fraction in the inhibition of thrombin and factor Xa. Thromb Haemost 1980; a; 44: 92-5.
    PubMedSearch in Google Scholar
  • 128 Tran T H, Bounameaux H, Bondeli C, Honkanen H, Marbet G A, Duckert F. Purification and partial characterization of a hereditary abnormal antithrombin III fraction of a patient with recurrent thrombophlebitis. Thromb Haemost 1980; b; 44: 87-91.
    PubMedSearch in Google Scholar
  • 129 Usharani P, Warn-Cramer B J, Kaspar C K, Bajai S P. Characterization of three abnormal factor IX variants (Bm Lake Elsinore, Long Beach, Los Angeles) of hemophilia B. Evidence for defects affecting the latent catalytic site. J Clin Invest 1985; 75: 76-83.
    CrossrefPubMedSearch in Google Scholar
  • 130 Vehar G A, Keyt B, Eaton D, Rodriguez H, O’Brien D P, Rotblat F, Oppermann H, Keck R, Wood W I, Harkins R N, Tuddenham E G D, Lawn R M, Capon D J. Structure of human factor VIII. Nature 1984; 312: 337-42.
    CrossrefPubMedSearch in Google Scholar
  • 131 Veltkamp J J, Meilof J, Remmelts H G, van der Vlerk D, Loeliger E A. Another genetic variant of hemophilia B: Hemophilia B Leyden. Scand J Haemat 1970; 07: 82-90.
    PubMedSearch in Google Scholar
  • 132 Weininger R S, Rudy C, Moake J L, Olson J D, Cimo P L. Prothrombin Houston: A dysprothrombin identifiably by crossed immunelectrofocusing an abnormal Echis carinatus venom activation. Blood 1980; 55: 811-6.
    PubMedSearch in Google Scholar
  • 133 Winship P R, Anson D S, Rizza C R, Brownlee G G. Diagnosis of carriers of haemophilia B using cloned gene probes. Thromb Haemost 1985; 54: 55.
    PubMedSearch in Google Scholar
  • 134 Winter R M, Tuddenham E G D, Goldman E, Matthews K B. A maximum likelihood estimate of the sex ration of mutation rates in haemophilia A. Hum Genet 1983; 64: 156-9.
    CrossrefPubMedSearch in Google Scholar
  • 135 Wolf M, Boyer C, Lavergne J M, Larrieu M J. A new familial variant of antithrombin III: Antithrombin III Paris. Brit J Haemat 1982; 51: 285-95.
    CrossrefPubMedSearch in Google Scholar
  • 136 Yang H C. Purification and immunological studies of factor IX Worcester. Blood 1977; 50 (Suppl 1): 289.
    PubMedSearch in Google Scholar
  • 137 Yu S, Sher B, Kudryk R, Redman C M. Intracellular assembly of human fibrinogen. J Biol Chem 1983; 258: 13407-10.
    PubMedSearch in Google Scholar